🇺🇸 FDA
Pipeline program

NIFEDIPINE, Placebo of Nifedipine

P160917

Phase 3 small_molecule active

Quick answer

NIFEDIPINE, Placebo of Nifedipine for obstetric_pathological delivery is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
obstetric_pathological delivery
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials